Joshua D. Hamermesh
Directeur/Membre du Conseil chez NeuroHealing Pharmaceuticals, Inc.
Profil
Joshua D.
Hamermesh is currently the Director at NeuroHealing Pharmaceuticals, Inc. and Independent Director at LIPAC Oncology LLC.
He previously worked as the Principal at Guidant Corp., Chief Operating Officer-MG Biotherapeutics Unit at Genzyme Corp., Senior VP-Strategy & Corporate Development at Pervasis Therapeutics, Inc., VP-Commercial & Business Development at Molecular Insight Pharmaceuticals, Inc., Vice President-Business & Corporate Development at Infinity Pharmaceuticals, Inc., Chief Operating Officer at MG Biotherapeutics LLC, Chief Business Officer at Gamida Cell Ltd., Senior Vice President at Locust Walk Partners LLC, and Senior Vice President-Business Development at Centessa Pharmaceuticals Plc.
He received his undergraduate degree from Amherst College and his MBA from Harvard Business School.
Postes actifs de Joshua D. Hamermesh
| Sociétés | Poste | Début |
|---|---|---|
NeuroHealing Pharmaceuticals, Inc.
 NeuroHealing Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NeuroHealing Pharmaceuticals, Inc. develops drug therapies for the post-acute and chronic neuro-rehabilitation patients. Its products include NH001, a dopaminergic agent to help post traumatic brain injury patients to emerge from a coma, vegetative, or minimally consciousness state, NH004, a treatment for the social debilitating condition of sialorrhea, a non-motor complaint of Parkinson's disease patients and NH02D, an orally administered drug for on-demand treatment of premature ejaculation, a male sexual disorder affecting sexually active men. The company was founded by Esteban Fridman and Daniel Katzman in 2003 and is headquartered in Waban, MA. | Directeur/Membre du Conseil | 08/07/2014 |
LIPAC Oncology LLC
 LIPAC Oncology LLC Medical DistributorsDistribution Services LIPAC Oncology LLC engages in the provision of drug delivery services. It offers LiPax, a proliposomal intracavitary paclitaxel drug delivery platform. The company was founded by Ramachandran R. Thirucote, Willem A. Robberts and Michael Oefelein in 2016 and is headquartered in Pomona, CA. | Directeur/Membre du Conseil | 06/05/2021 |
Anciens postes connus de Joshua D. Hamermesh
| Sociétés | Poste | Fin |
|---|---|---|
| CENTESSA PHARMACEUTICALS PLC | Corporate Officer/Principal | 01/02/2023 |
Locust Walk Partners LLC
 Locust Walk Partners LLC Miscellaneous Commercial ServicesCommercial Services Locust Walk Partners LLC provides commercial supporting and advisory services. The firm involves in securities-related transactions for clients, including mergers and acquisitions, private placements & mezzanine financings and partnerships involving equity investments. The company was founded by Geoff Meyerson and Joseph Mohr in 2008 and is headquartered in Boston, MA. | Corporate Officer/Principal | 01/01/2018 |
| INFINITY PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/02/2014 |
Pervasis Therapeutics, Inc.
 Pervasis Therapeutics, Inc. Medical SpecialtiesHealth Technology Pervasis Therapeutics, Inc. is a clinical stage company developing a broad portfolio of biologically active therapeutics. The company was founded by Robert S. Langer Jr. and Helen Marie Nugent in 2004 and is headquartered in Waltham, MA. | Corporate Officer/Principal | 01/01/2011 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/01/2005 |
Formation de Joshua D. Hamermesh
| Amherst College | Undergraduate Degree |
| Harvard Business School | Masters Business Admin |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| INFINITY PHARMACEUTICALS, INC. | Health Technology |
| GAMIDA CELL LTD. | Health Technology |
| CENTESSA PHARMACEUTICALS PLC | Health Technology |
| Entreprise privées | 9 |
|---|---|
Guidant Corp.
 Guidant Corp. Medical SpecialtiesHealth Technology Guidant Corp. manufactures cardiovascular therapeutic devices. The company also provides cardiac and peripheral vascular repair surgical systems. It operates in Europe and Japan. Guidant was founded in 1994 and is headquartered in St. Paul, MN. | Health Technology |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Pervasis Therapeutics, Inc.
Pervasis Therapeutics, Inc. Medical SpecialtiesHealth Technology Pervasis Therapeutics, Inc. is a clinical stage company developing a broad portfolio of biologically active therapeutics. The company was founded by Robert S. Langer Jr. and Helen Marie Nugent in 2004 and is headquartered in Waltham, MA. | Health Technology |
Molecular Insight Pharmaceuticals, Inc.
 Molecular Insight Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Molecular Insight Pharmaceuticals, Inc. engages in developing and commercializing innovative molecular imaging pharmaceuticals and targeted radiotherapeutics to diagnose and treat disease. The company was founded in 1997 and the company is headquartered in Cambridge, MA. | Health Services |
Monitor
 Monitor Financial ConglomeratesFinance Monitor is an American private investment company. | Finance |
| MG Biotherapeutics LLC | |
NeuroHealing Pharmaceuticals, Inc.
NeuroHealing Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NeuroHealing Pharmaceuticals, Inc. develops drug therapies for the post-acute and chronic neuro-rehabilitation patients. Its products include NH001, a dopaminergic agent to help post traumatic brain injury patients to emerge from a coma, vegetative, or minimally consciousness state, NH004, a treatment for the social debilitating condition of sialorrhea, a non-motor complaint of Parkinson's disease patients and NH02D, an orally administered drug for on-demand treatment of premature ejaculation, a male sexual disorder affecting sexually active men. The company was founded by Esteban Fridman and Daniel Katzman in 2003 and is headquartered in Waban, MA. | Health Technology |
Locust Walk Partners LLC
Locust Walk Partners LLC Miscellaneous Commercial ServicesCommercial Services Locust Walk Partners LLC provides commercial supporting and advisory services. The firm involves in securities-related transactions for clients, including mergers and acquisitions, private placements & mezzanine financings and partnerships involving equity investments. The company was founded by Geoff Meyerson and Joseph Mohr in 2008 and is headquartered in Boston, MA. | Commercial Services |
LIPAC Oncology LLC
LIPAC Oncology LLC Medical DistributorsDistribution Services LIPAC Oncology LLC engages in the provision of drug delivery services. It offers LiPax, a proliposomal intracavitary paclitaxel drug delivery platform. The company was founded by Ramachandran R. Thirucote, Willem A. Robberts and Michael Oefelein in 2016 and is headquartered in Pomona, CA. | Distribution Services |
